Jpmorgan Chase & CO Alpha Teknova, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,400 shares of TKNO stock, worth $29,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,400
Previous 609
622.5%
Holding current value
$29,700
Previous $2,000
1700.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding TKNO
# of Institutions
47Shares Held
6.45MCall Options Held
0Put Options Held
0-
Ubs Group Ag1.11MShares$7.51 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.11MShares$7.47 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1MShares$6.76 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA540KShares$3.65 Million0.0% of portfolio
-
Parian Global Management LP Pound Ridge, NY290KShares$1.96 Million3.15% of portfolio
About Alpha Teknova, Inc.
- Ticker TKNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 28,080,500
- Market Cap $190M
- Description
- Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...